)

Lantheus (LNTH) investor relations material
Lantheus Morgan Stanley 23rd Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and market position
Focused on nuclear medicine, with a legacy dating back to the Manhattan Project and a portfolio including Cardiolite, technetium generators, PYLARIFY®, and DEFINITY®.
PYLARIFY® surpassed $1 billion in sales but faces reimbursement and competitive headwinds, with about 20% of patients affected by recent Medicare changes.
The PSMA PET market is currently a three-player field, with expectations for additional competitors by 2026-2028 and significant growth driven by prostate cancer demand.
Maintains leadership through product differentiation, superior F-18 technology, strong field team, and reliable delivery.
Product innovation and pipeline development
New PYLARIFY® formulation is under FDA review, with anticipated approval in March next year, aiming to increase batch size by 50% and improve efficiency and margins.
Multiple launches expected in the next two years, including Octavi for neuroendocrine tumors and expansion of NeuroCeq™.
Pipeline includes agents for small cell lung cancer, osteosarcoma (LLRC-15), and prostate cancer (RM2), with ongoing clinical trials and regulatory filings planned.
Focus on Alzheimer's and dementia, with NeuroCeq™ and MK6240 targeting beta amyloid and TAL, and a phase three cardiac amyloidosis study underway.
Strategic business development and integration
Recent acquisitions of Evergreen and LMI enhance manufacturing, R&D, and commercial capabilities, especially in radionuclide and amyloid spaces.
Integration is progressing well, with asset and team synergies being realized, and a focus on expanding commercial reach for NeuroCeq™.
Divestiture of the SPECT business improves gross margin by 200 basis points and unlocks growth potential.
Business development will remain selective, prioritizing tuck-in acquisitions and early ROI, with an R&D day planned to showcase pipeline progress.
Next Lantheus earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage